Want to see SG:9G2 full AI Analyst Report?

Singapore Institute of Advanced Medicine Holdings Ltd. (9G2) Ratios

6 Followers

Singapore Institute of Advanced Medicine Holdings Ltd. Ratios

SG:9G2's free cash flow for Q3 2025 was S$-0.36. For the 2025 fiscal year, SG:9G2's free cash flow was decreased by S$ and operating cash flow was S$-1.26. See a summary of the company’s cash flow.

Ratios	TTM	Jun 25	Jun 24	Jun 24	Jun 23
Liquidity Ratios
Current Ratio	―	0.52	0.37	0.31	0.25
Quick Ratio	―	0.52	0.36	0.30	0.25
Cash Ratio	―	0.44	0.25	0.17	0.21
Solvency Ratio	―	-0.17	-0.44	-0.21	-0.11
Operating Cash Flow Ratio	―	-0.11	-1.14	-0.62	-0.10
Short-Term Operating Cash Flow Coverage	―	-0.19	-3.73	-1.12	-0.20
Net Current Asset Value	S$ ―	S$ -61.01M	S$ -52.35M	S$ -63.76M	S$ -101.16M
Leverage Ratios
Debt-to-Assets Ratio	―	0.46	0.33	0.47	0.51
Debt-to-Equity Ratio	―	1.16	0.56	1.05	1.80
Debt-to-Capital Ratio	―	0.54	0.36	0.51	0.64
Long-Term Debt-to-Capital Ratio	―	0.17	0.11	0.25	0.32
Financial Leverage Ratio	―	2.50	1.70	2.24	3.55
Debt Service Coverage Ratio	―	-0.39	-0.87	-0.88	-0.36
Interest Coverage Ratio	―	-4.90	-1.84	-7.05	-5.97
Debt to Market Cap	―	0.80	0.13	0.93	0.78
Interest Debt Per Share	―	0.05	0.06	0.06	0.26
Net Debt to EBITDA	―	-5.14	-3.20	-5.00	-6.58
Profitability Margins
Gross Profit Margin	―	92.23%	92.27%	91.77%	-16.03%
EBIT Margin	―	-125.75%	-155.50%	-146.29%	-101.91%
EBITDA Margin	―	-57.10%	-80.60%	-70.50%	-65.32%
Operating Profit Margin	―	-128.51%	-127.60%	-142.27%	-89.01%
Pretax Profit Margin	―	-151.97%	-224.91%	-166.48%	-116.82%
Net Profit Margin	―	-152.04%	-224.95%	-166.53%	-111.32%
Continuous Operations Profit Margin	―	-151.97%	-224.91%	-166.48%	-116.82%
Net Income Per EBT	―	100.04%	100.02%	100.03%	95.29%
EBT Per EBIT	―	118.26%	176.26%	117.02%	131.24%
Return on Assets (ROA)	―	-18.09%	-26.99%	-20.98%	-11.33%
Return on Equity (ROE)	―	-45.16%	-45.81%	-47.02%	-40.22%
Return on Capital Employed (ROCE)	―	-20.74%	-16.83%	-20.77%	-13.56%
Return on Invested Capital (ROIC)	―	-16.91%	-16.01%	-18.80%	-10.80%
Return on Tangible Assets	―	-18.09%	-26.99%	-20.98%	-11.33%
Earnings Yield	―	-64.68%	-35.37%	-85.74%	-29.22%
Efficiency Ratios
Receivables Turnover	―	6.35	14.90	9.85	9.31
Payables Turnover	―	0.10	1.71	0.22	24.73
Inventory Turnover	―	11.19	12.51	11.28	178.36
Fixed Asset Turnover	―	0.14	0.13	0.14	0.11
Asset Turnover	―	0.12	0.12	0.13	0.10
Working Capital Turnover Ratio	―	-1.11	-0.70	-1.60	-0.47
Cash Conversion Cycle	―	-3.70K	-160.06	-1.58K	26.47
Days of Sales Outstanding	―	57.45	24.50	37.04	39.19
Days of Inventory Outstanding	―	32.62	29.18	32.35	2.05
Days of Payables Outstanding	―	3.79K	213.74	1.65K	14.76
Operating Cycle	―	90.06	53.68	69.40	41.23
Cash Flow Ratios
Operating Cash Flow Per Share	―	>-0.01	-0.01	-0.01	-0.02
Free Cash Flow Per Share	―	>-0.01	-0.01	-0.01	-0.06
CapEx Per Share	―	<0.01	<0.01	<0.01	0.04
Free Cash Flow to Operating Cash Flow	―	1.13	1.04	1.01	3.65
Dividend Paid and CapEx Coverage Ratio	―	-7.46	-26.70	-71.93	-0.38
Capital Expenditure Coverage Ratio	―	-7.46	-26.70	-71.93	-0.38
Operating Cash Flow Coverage Ratio	―	-0.06	-0.31	-0.18	-0.07
Operating Cash Flow to Sales Ratio	―	-0.23	-0.86	-0.68	-0.34
Free Cash Flow Yield	―	-11.19%	-13.98%	-35.32%	-32.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-1.55	-2.83	-1.16	-3.42
Price-to-Sales (P/S) Ratio	―	2.35	6.36	1.94	3.81
Price-to-Book (P/B) Ratio	―	0.70	1.29	0.55	1.38
Price-to-Free Cash Flow (P/FCF) Ratio	―	-8.93	-7.15	-2.83	-3.11
Price-to-Operating Cash Flow Ratio	―	-10.13	-7.42	-2.87	-11.35
Price-to-Earnings Growth (PEG) Ratio	―	0.07	0.08	0.04	-0.08
Price-to-Fair Value	―	0.70	1.29	0.55	1.38
Enterprise Value Multiple	―	-9.25	-11.09	-7.75	-12.41
Enterprise Value	―	83.05M	148.79M	85.88M	131.58M
EV to EBITDA	―	-9.25	-11.09	-7.75	-12.41
EV to Sales	―	5.28	8.94	5.47	8.11
EV to Free Cash Flow	―	-20.08	-10.06	-7.97	-6.62
EV to Operating Cash Flow	―	-22.77	-10.43	-8.08	-24.14
Tangible Book Value Per Share	―	0.04	0.08	0.05	0.14
Shareholders’ Equity Per Share	―	0.04	0.08	0.05	0.14
Tax and Other Ratios
Effective Tax Rate	―	0.00	0.00	0.00	0.00
Revenue Per Share	―	0.01	0.02	0.01	0.05
Net Income Per Share	―	-0.02	-0.04	-0.02	-0.06
Tax Burden	―	1.00	1.00	1.00	0.95
Interest Burden	―	1.21	1.45	1.14	1.15
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.10	0.13	0.10	0.13
Stock-Based Compensation to Revenue	―	0.00	>-0.01	<0.01	0.03
Income Quality	―	0.15	0.38	0.41	0.29

Currency in SGD